A pilot study led by the Translational Genomics Research Institute and the Virginia G. Piper Cancer Center at Scottsdale Healthcare shows that, even for patients with advanced and rapidly transforming cancer, next generation sequencing is feasible. While the initial effort was a slower process than anticipated due to a variety of issues, treatments for patients with progressing tumours may be improved. Read more here.
Study mentioned: Weiss GJ, et al. (2013) A Pilot Study Using Next-Generation Sequencing in Advanced Cancers: Feasibility and Challenges. PLoS ONE 8(10): e76438.
No comments:
Post a Comment